Avalo Therapeutics AVTX
NASDAQ AVTX
$15.33 -0.25 (-1.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Other financing activities (2019 - 2026)

Updated

Avalo Therapeutics' Other financing activities came in at $779,000 for Q1 2026.

Analysis

Avalo Therapeutics (AVTX) Other financing activities (2019 - 2026) Analysis & Trends

For FY2025, Avalo Therapeutics' Other financing activities was $510,000.

  • Other financing activities carries a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Avalo Therapeutics 668.42 Mn 668.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 779,000.00
Sep 30, 2025 1,000.00
Jun 30, 2025 509,000.00
Sep 30, 2019 15,902.00
API Access

Avalo Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AVTX&period=max&api_key=YOUR_API_KEY